Savara announces participation in the 43rd annual j.p. morgan healthcare conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra) (the company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the company will present and host 1x1 meetings at the 43rd annual j.p. morgan healthcare conference. date/time of presentation: january 15, 5:15pm pt/8:15pm et presenter: matt pauls, chair and chief executive officer, savara location: westin st. francis, san francisco, elizabethan c room the live webcast and subsequent r.
SVRA Ratings Summary
SVRA Quant Ranking